{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:06:54Z","timestamp":1791562014785,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI057266\\u201315"],"award-info":[{"award-number":["U19AI057266\\u201315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PID2021-127281OB-I00"],"award-info":[{"award-number":["PID2021-127281OB-I00"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["RTI2018\\u2013100701-B-I00"],"award-info":[{"award-number":["RTI2018\\u2013100701-B-I00"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GOLDBE20P0"],"award-info":[{"award-number":["GOLDBE20P0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GOLDBE20G0"],"award-info":[{"award-number":["GOLDBE20G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126476","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T08:33:31Z","timestamp":1730363611000},"page":"126476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pseudomonas aeruginosa elongation factor-Tu (EF-Tu) is an immunogenic protective protein antigen"],"prefix":"10.1016","volume":"42","author":[{"given":"Dina A.","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Schafer-Kestenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margalida","family":"Mateu-Borr\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dom\u00e9nech-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Albert\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126476_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-113009-092313","article-title":"Structural basis of the translational elongation cycle","volume":"82","author":"Voorhees","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2024.126476_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/mmi.13750","article-title":"Elfamycins: inhibitors of elongation factor-Tu","volume":"106","author":"Prezioso","year":"2017","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/261023a0","article-title":"Abundance and membrane association of elongation factor Tu in E. coli","volume":"261","author":"Jacobson","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.126476_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1432-1033.1981.tb05079.x","article-title":"Appearance of elongation factor Tu in the outer membrane of sucrose-dependent spectinomycin-resistant mutants of Escherichia coli","volume":"113","author":"Dombou","year":"1981","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2024.126476_bb0025","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/jb.172.9.5147-5153.1990","article-title":"Nutrient-dependent methylation of a membrane-associated protein of Escherichia coli","volume":"172","author":"Young","year":"1990","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0030","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1128\/IAI.66.6.2625-2631.1998","article-title":"Mapping and identification of the major cell wall-associated components of Mycobacterium leprae","volume":"66","author":"Marques","year":"1998","journal-title":"Infect Immun"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2024.126476_bb0035","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1099\/00221287-142-9-2481","article-title":"Identification of an EF-Tu protein that is periplasm-associated and processed in Neisseria gonorrhoeae","volume":"142","author":"Porcella","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2024.126476_bb0040","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1128\/IAI.00173-08","article-title":"The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin","volume":"76","author":"Balasubramanian","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126476_bb0045","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/IAI.72.4.2160-2169.2004","article-title":"Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins","volume":"72","author":"Granato","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126476_bb0050","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1002\/pmic.200400928","article-title":"The cell wall subproteome of Listeria monocytogenes","volume":"4","author":"Schaumburg","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2024.126476_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2180-8-145","article-title":"A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu","volume":"8","author":"Barel","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1574-695X.2008.00419.x","article-title":"The surface-associated elongation factor Tu is concealed for antibody binding on viable pneumococci and meningococci","volume":"53","author":"Kolberg","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0065","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1128\/IAI.00179-11","article-title":"Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease","volume":"79","author":"Henderson","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126476_bb0070","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1038\/s41598-017-10644-z","article-title":"Elongation factor Tu is a multifunctional and processed moonlighting protein","volume":"7","author":"Widjaja","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.126476_bb0075","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/21505594.2020.1806664","article-title":"Mycoplasma hyopneumoniae evades complement activation by binding to factor H via elongation factor thermo unstable (EF-Tu)","volume":"11","author":"Yu","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2024.126476_bb0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2015.09.027","article-title":"An interbacterial NAD(P)(+) glycohydrolase toxin requires elongation factor Tu for delivery to target cells","volume":"163","author":"Whitney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.126476_bb0085","doi-asserted-by":"crossref","first-page":"E1951","DOI":"10.1073\/pnas.1619273114","article-title":"Activation of contact-dependent antibacterial tRNase toxins by translation elongation factors","volume":"114","author":"Jones","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126476_bb0090","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.4049\/jimmunol.179.5.2979","article-title":"Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein","volume":"179","author":"Kunert","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/525048","article-title":"Novel phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic infection isolates interacts with airway epithelial cells","volume":"197","author":"Barbier","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126476_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01276-17","article-title":"Functional constraints on replacing an essential gene with its ancient and modern homologs","volume":"8","author":"Kacar","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.126476_bb0105","doi-asserted-by":"crossref","first-page":"D646","DOI":"10.1093\/nar\/gkv1227","article-title":"Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database","volume":"44","author":"Winsor","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.126476_bb0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbapap.2011.02.007","article-title":"Construction of a fully active Cys-less elongation factor Tu: functional role of conserved cysteine 81","volume":"1814","author":"De Laurentiis","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2024.126476_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/585748","article-title":"Cloning and characterization of EF-Tu and EF-Ts from Pseudomonas aeruginosa","volume":"2013","author":"Palmer","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2024.126476_bb0120","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/AEM.00640-13","article-title":"Construction of mobilizable mini-Tn7 vectors for bioluminescent detection of gram-negative bacteria and single-copy promoter lux reporter analysis","volume":"79","author":"Damron","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0125","doi-asserted-by":"crossref","first-page":"e00207","DOI":"10.1128\/mBio.00207-13","article-title":"Lysine trimethylation of EF-Tu mimics platelet-activating factor to initiate Pseudomonas aeruginosa pneumonia","volume":"4","author":"Barbier","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.126476_bb0130","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1128\/AEM.01369-08","article-title":"PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria","volume":"74","author":"Qiu","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0135","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1074\/jbc.M115.706853","article-title":"Pseudomonas aeruginosa EftM is a thermoregulated methyltransferase","volume":"291","author":"Owings","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2024.126476_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0022-2836(92)90986-T","article-title":"Refined structure of elongation factor EF-Tu from Escherichia coli","volume":"223","author":"Kjeldgaard","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0145","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3389\/fmicb.2019.02351","article-title":"The diverse functional roles of elongation factor Tu (EF-Tu) in microbial pathogenesis","volume":"10","author":"Harvey","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0150","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D","article-title":"Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera","volume":"20","author":"Sanchez-Campillo","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2024.126476_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2015.54","article-title":"Borrelia burgdorferi elongation factor EF-Tu is an immunogenic protein during Lyme borreliosis","volume":"4","author":"Carrasco","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.126476_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1523-5378.2002.00078.x","article-title":"Proteome analysis of highly immunoreactive proteins of Helicobacter pylori","volume":"7","author":"Lock","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.vaccine.2024.126476_bb0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G","article-title":"Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis","volume":"2","author":"Vytvytska","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2024.126476_bb0170","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/IAI.00617-08","article-title":"Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus","volume":"77","author":"Glowalla","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126476_bb0175","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1128\/AEM.00455-06","article-title":"Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis","volume":"72","author":"Delvecchio","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1515\/pjvs-2017-0033","article-title":"Expression and immunological evaluation of elongation factor Tu of Streptococcus suis serotype 2","volume":"20","author":"Xia","year":"2017","journal-title":"Pol J Vet Sci"},{"key":"10.1016\/j.vaccine.2024.126476_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014361","article-title":"Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization","volume":"5","author":"Nieves","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126476_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080796","article-title":"Immunoproteomic analysis of proteins expressed by two related pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during human infection","volume":"8","author":"Shinoy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126476_bb0195","first-page":"61","article-title":"Identification of high immunoreactive proteins from Streptococcus agalactiae isolates recognized by human serum antibodies","volume":"349","author":"Brzychczy-Wloch","year":"2013","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2024.126476_bb0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fmicb.2018.00125","article-title":"Epitope mapping of Streptococcus agalactiae elongation factor Tu protein recognized by human sera","volume":"9","author":"Pyclik","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0205","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.3389\/fimmu.2018.02910","article-title":"EF-Tu from non-typeable Haemophilus influenzae is an immunogenic surface-exposed protein targeted by bactericidal antibodies","volume":"9","author":"Thofte","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/eji.201847871","article-title":"Anti-EF-Tu IgG titers increase with age and may contribute to protection against the respiratory pathogen Haemophilus influenzae","volume":"49","author":"Thofte","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cellimm.2011.03.023","article-title":"TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu","volume":"269","author":"Sharma","year":"2011","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.vaccine.2018.11.015","article-title":"Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection","volume":"37","author":"Nagai","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126476_bb0225","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post hoc analysis of a prospective cohort","volume":"57","author":"Pena","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126476_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1099\/mic.0.000860","article-title":"Microbe profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat","volume":"166","author":"Diggle","year":"2020","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.vaccine.2024.126476_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00294-015-0522-x","article-title":"Pseudomonas aeruginosa: breaking down barriers","volume":"62","author":"Berube","year":"2016","journal-title":"Curr Genet"},{"key":"10.1016\/j.vaccine.2024.126476_bb0240","series-title":"Cystic Fibrosis Foundation Patient Registry 2020Annual Data Report","author":"Anonymous","year":"2021"},{"key":"10.1016\/j.vaccine.2024.126476_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122617","article-title":"Understanding Pseudomonas aeruginosa-host interactions: the ongoing quest for an efficacious vaccine","volume":"9","author":"Sainz-Mejias","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2024.126476_bb0250","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.mucimm.2023.03.005","article-title":"Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection","volume":"16","author":"Pitiot","year":"2023","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2024.126476_bb0255","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/14760584.2014.890053","article-title":"Vaccines for Pseudomonas aeruginosa: a long and winding road","volume":"13","author":"Priebe","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.126476_bb0260","doi-asserted-by":"crossref","DOI":"10.1089\/sur.2018.233","article-title":"Progress toward the elusive Pseudomonas aeruginosa vaccine","author":"Merakou","year":"2018","journal-title":"Surg Infect"},{"key":"10.1016\/j.vaccine.2024.126476_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:44:30Z","timestamp":1741887870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24011587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24011587"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126476","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudomonas aeruginosa elongation factor-Tu (EF-Tu) is an immunogenic protective protein antigen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126476"}}